News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,979 Results
Type
Article (40962)
Company Profile (273)
Press Release (661744)
Section
Business (205828)
Career Advice (2129)
Deals (35656)
Drug Delivery (99)
Drug Development (81828)
Employer Resources (175)
FDA (16313)
Job Trends (14994)
News (348423)
Policy (33288)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2601)
Accelerated approval (2)
Adcomms (25)
Allergies (82)
Alliances (49994)
ALS (84)
Alzheimer's disease (1377)
Antibody-drug conjugate (ADC) (115)
Approvals (16297)
Artificial intelligence (229)
Autoimmune disease (15)
Automation (14)
Bankruptcy (362)
Best Places to Work (11722)
BIOSECURE Act (20)
Biosimilars (103)
Biotechnology (192)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (247)
Cancer (1995)
Cardiovascular disease (153)
Career advice (1779)
Career pathing (30)
CAR-T (141)
Cell therapy (397)
Cervical cancer (18)
Clinical research (66211)
Collaboration (770)
Compensation (446)
Complete response letters (23)
COVID-19 (2631)
CRISPR (35)
C-suite (206)
Cystic fibrosis (98)
Data (1904)
Decentralized trials (2)
Denatured (18)
Depression (39)
Diabetes (248)
Diagnostics (6452)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (110)
Drug pricing (100)
Drug shortages (27)
Duchenne muscular dystrophy (88)
Earnings (86449)
Editorial (33)
Employer branding (21)
Employer resources (148)
Events (112703)
Executive appointments (635)
FDA (17410)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (697)
Gene editing (97)
Generative AI (20)
Gene therapy (277)
GLP-1 (705)
Government (4530)
Grass and pollen (4)
Guidances (48)
Healthcare (18983)
Huntington's disease (24)
IgA nephropathy (21)
Immunology and inflammation (110)
Indications (26)
Infectious disease (2763)
Inflammatory bowel disease (137)
Inflation Reduction Act (10)
Influenza (46)
Intellectual property (85)
Interviews (337)
IPO (16574)
IRA (42)
Job creations (3694)
Job search strategy (1509)
Kidney cancer (10)
Labor market (34)
Layoffs (461)
Leadership (16)
Legal (8196)
Liver cancer (71)
Lung cancer (298)
Lymphoma (130)
Machine learning (2)
Management (60)
Manufacturing (269)
MASH (61)
Medical device (13375)
Medtech (13380)
Mergers & acquisitions (19546)
Metabolic disorders (634)
Multiple sclerosis (69)
NASH (18)
Neurodegenerative disease (81)
Neuropsychiatric disorders (24)
Neuroscience (1851)
NextGen: Class of 2025 (6601)
Non-profit (4557)
Northern California (2394)
Now hiring (37)
Obesity (347)
Opinion (217)
Ovarian cancer (71)
Pain (78)
Pancreatic cancer (78)
Parkinson's disease (133)
Partnered (18)
Patents (202)
Patient recruitment (94)
Peanut (48)
People (57593)
Pharmaceutical (67)
Pharmacy benefit managers (19)
Phase I (20659)
Phase II (29166)
Phase III (21706)
Pipeline (970)
Podcasts (48)
Policy (112)
Postmarket research (2578)
Preclinical (8761)
Press Release (65)
Prostate cancer (91)
Psychedelics (32)
Radiopharmaceuticals (244)
Rare diseases (359)
Real estate (5964)
Recruiting (66)
Regulatory (22503)
Reports (46)
Research institute (2352)
Resumes & cover letters (365)
Rett syndrome (3)
RNA editing (2)
RSV (39)
Schizophrenia (64)
Series A (124)
Series B (79)
Service/supplier (13)
Sickle cell disease (49)
Southern California (2082)
Special edition (16)
Spinal muscular atrophy (150)
Sponsored (28)
Startups (3646)
State (2)
Stomach cancer (12)
Supply chain (60)
The Weekly (27)
United States (20988)
Vaccines (669)
Venture capitalists (38)
Webinars (12)
Weight loss (233)
Women's health (33)
Worklife (16)
Date
Today (28)
Last 7 days (571)
Last 30 days (2627)
Last 365 days (33832)
2025 (7706)
2024 (35585)
2023 (40409)
2022 (51511)
2021 (56061)
2020 (54483)
2019 (47066)
2018 (35501)
2017 (32459)
2016 (31875)
2015 (37929)
2014 (31628)
2013 (26667)
2012 (28932)
2011 (29591)
2010 (27655)
Location
Africa (738)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (38131)
Australia (6289)
California (5483)
Canada (1856)
China (471)
Colorado (247)
Connecticut (260)
Delaware (123)
Europe (82470)
Florida (809)
Georgia (190)
Idaho (58)
Illinois (496)
India (24)
Indiana (289)
Iowa (9)
Japan (138)
Kansas (103)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (830)
Massachusetts (4110)
Michigan (208)
Minnesota (366)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (63)
New Jersey (1551)
New Mexico (28)
New York (1567)
North Carolina (920)
North Dakota (7)
Northern California (2394)
Ohio (192)
Oklahoma (14)
Oregon (35)
Pennsylvania (1244)
Puerto Rico (9)
Rhode Island (27)
South America (1120)
South Carolina (18)
South Dakota (1)
Southern California (2082)
Tennessee (92)
Texas (815)
Utah (164)
Virginia (131)
Washington D.C. (58)
Washington State (510)
West Virginia (3)
Wisconsin (54)
702,979 Results for "actio biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Actio Biosciences to Participate in Upcoming March 2025 Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Actio Biosciences Expands Leadership Team with Appointment of Cayce Denton as Chief Financial Officer
January 8, 2025
·
2 min read
Press Releases
Actio Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
Actio Biosciences to Participate in Upcoming Investor Conferences
November 12, 2024
·
1 min read
Press Releases
Actio Biosciences Announces First Participant Dosed in Phase 1 Clinical Trial of ABS-0871, a Novel TRPV4 Inhibitor, for the Treatment of Charcot Marie Tooth Disease 2C
March 3, 2025
·
3 min read
Business
Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors
Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced that Ben Cravatt, Ph.D., has joined the company’s board of directors.
May 22, 2024
·
2 min read
Business
Actio Biosciences to Participate in Upcoming October Investor Conferences
September 25, 2024
·
1 min read
Business
Actio Biosciences Appoints Samuel Collins, MBBS, Ph.D., MBA, as Chief Medical Officer as Company Advances Multiple Precision Medicine Programs Toward Clinical Development
Actio Biosciences today announced that Samuel Collins, Ph.D., has joined the company as chief medical officer to oversee all aspects of clinical development, as well as medical and regulatory affairs, for the company’s pipeline of precision medicines.
January 24, 2024
·
2 min read
Biotech Beach
Actio Biosciences Announces $55 Million Series A Financing to Advance Precision Medicine Approach for Rare and Common Diseases
Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, announced the completion of a $55 million Series A financing.
September 12, 2023
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results
March 19, 2025
·
6 min read
1 of 70,298
Next
